Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Breast Cancer
Published in: Breast Cancer 3/2004

01-08-2004 | Original Article

Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapy

Authors: Yoshinari Ogawa, Takuya Moriya, Yasuyuki Kato, Mitsue Oguma, Katsumi Ikeda, Tsutomu Takashima, Bunzo Nakata, Tetsuro Ishikawa, Kosei Hirakawa

Published in: Breast Cancer | Issue 3/2004

Login to get access
Metadata
Title
Immunohistochemical assessment for estrogen receptor and progesterone receptor status in breast cancer: Analysis for a cut-off point as the predictor for endocrine therapy
Authors
Yoshinari Ogawa
Takuya Moriya
Yasuyuki Kato
Mitsue Oguma
Katsumi Ikeda
Tsutomu Takashima
Bunzo Nakata
Tetsuro Ishikawa
Kosei Hirakawa
Publication date
01-08-2004
Publisher
Springer-Verlag
Published in
Breast Cancer / Issue 3/2004
Print ISSN: 1340-6868
Electronic ISSN: 1880-4233
DOI
https://doi.org/10.1007/BF02984548

Other articles of this Issue 3/2004

Breast Cancer 3/2004 Go to the issue

Short Paper

Expression of cdc25A and cdc25B phosphatase in breast carcinoma

Short Paper

Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast

Original Article

Optimal particle size of radiocolloid for sentinel node identification in breast cancer — Electron microscopic study and clinical comparison

Case Report

Successful combination therapy with trastuzumab and paclitaxel for adriamycin- and docetaxel-resistant inflammatory breast cancer

Case Report

A case of invasive lobular carcinoma of the breast first manifesting with duodenal obstruction

Original Article

Is early recognition of radiologically silent brain metastasis from breast cancer beneficial? A retrospective study of 22 cases
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits